PaxVax, Inc. Employee Directory
Biotechnology ResearchCalifornia, United States201-500 Employees
PaxVax, Inc. is a biotechnology company focused on vaccine research and development, based in Redwood City, California. Its work has included programs aimed at infectious diseases, most notably a chikungunya vaccine candidate, and it has engaged in collaborative research such as a 2014 agreement with the University of California to develop a combination vaccine to prevent genital herpes simplex virus infections. In 2018, PaxVax was acquired by Emergent BioSolutions, integrating into Emergent's global portfolio of specialty biopharmaceutical products. The company sits in the biotechnology research sector, pursuing vaccine candidates to address infectious disease threats and public health needs, often through partnerships and development programs.